Clevidipine Bolus Administration in the Treatment of Hypertensive Patients Undergoing Cardiac Surgery (SPRINT)
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
This study was designed to evaluate the pharmacodynamics of a bolus dosing regimen of
clevidipine, a vascular-selective L-type calcium channel antagonist, for the management of
blood pressure in cardiac surgery patients, as well as to evaluate the efficacy, safety and
pharmacokinetics of clevidipine after bolus administration.